Special concern about squamous cell carcinoma of the scalp in organ transplant recipients

Archives of Dermatology

Volumn 142, Issue 6, 2006, Pages 755-758

  Cooper, Jennifer Z ^a   Brown, Marc D ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE;

ACTINIC KERATOSIS; AGED; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; CANCER RADIOTHERAPY; CASE REPORT; CHEMOSURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; DOSE RESPONSE; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; LAPAROTOMY; LYMPHADENOPATHY; MALE; NECK DISSECTION; ORGAN TRANSPLANTATION; PAPULE; PAROTIDECTOMY; PRIORITY JOURNAL; RADIATION DOSE; SKIN BIOPSY; SKIN METASTASIS; SKIN NODULE; SKIN SWELLING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SCALP; SKIN NEOPLASMS;

EID: 33745227418     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.6.755     Document Type: Article

References (14)

1. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47:1-17.
2. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513-519.
3. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation. 1996;61:715-721.
4. Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis. 2003;41:676-683.
5. Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol. 2002;147:950-956.
6. Karjalainen S, Salo H, Teppo L. Basal cell and squamous cell carcinoma of the skin in Finland: site distribution and patient survival. Int J Dermatol. 1989;28:445-450.
7. Davidovitz Y, Ballin A, Meytes D. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia. Acta Haematol. 1997;98:44-46.
8. Carucci JA, Martinez JC, Zeitouni NC, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg. 2004;30:651-655.
9. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976-990.
10. Pollard JD, Hanasono MM, Mikulec AA, Le QT, Terris DJ. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope. 2000;110:1257-1261.
11. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63:1727-1730.
12. Chao C, Wong SL, Edwards MJ, et al; Sunbelt Melanoma Trial Group. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 2003;10:21-26.
13. Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29:135-140.
14. Weisberg NK, Bertagnolli MM, Becker DS. Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2000;43:483-488.